Much research interest has lately been focused on the dopamine transporter
function in brain. Recent findings indicate that dopamine reuptake is more
like a highly regulated than a constitutive determinant of dopamine clearan
ce. Positron emission tomography (PET) and single-photon emission tomograph
y (SPET) offer unique methods to study dopamine transporter function. Resul
ts from in vivo PET and SPET studies correspond well with in vitro studies
performed on post mortem human brain tissue. Considering some of the varian
ces between in vitro and in vivo receptor binding phenomena it may be that
the role of a compound to alter binding to monoamine uptake sites in vitro
does not indicate its potential to affect monoamine transporters after admi
nistration in vivo. This discrepancy may be better understood taking into a
ccount recant studies indicating the possibility of a rapid regulation of t
ransporter function and surface expression. Furthermore, the dopamine trans
porter is a fruitful target for CNS drug discovery Fundamental nature of dr
ug actions in vivo may be studied using demonstrated in vitro and in vivo i
maging methods.